Researchers have examined the adverse outcomes of zafirlukast in adults and children aged 12 or older. Occasional experiences of eosinophilia accompanied by vasculitis in sufferers on zafirlukast have emerged. Zafirlukast is looked upon as "pregnancy category B." This is often because of, partially, on the broad protection margin of zafirlukast https://michaelq998dpz1.answerblogs.com/profile